According to Circana, 61% of GLP-1 users take the drug to lose weight, while 37% use it to help manage a condition like diabetes, and 35% take it because they want to feel healthier
Ibrance (palbociclib) Disease area(s): Oncology Manufacturer(s): Pfizer 2024 Sales (USD): $4.37 billion Why it sold so well: Pfizers Ibrance generated $4.37 billion in global revenue in 2024, maintaining its position as a leading therapy for hormone receptor-positive (HR+), HER2-negative metastatic breast cancer
17 Given that WC is a critical determinant of WHtR, the pronounced decrease in WC among semaglutide-treated patients suggests a likely improvement in WHtR and, by implication, cardiometabolic health
These higher sugar levels can ultimately cause damage to our blood vessels, as they can weaken the walls of the blood vessels
We're rated Excellent on Trustpilot and have over 10 years of experience working in both lifestyle and elite performance nutrition
There's a time and place where you should be avoiding them